You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Another reform plan for NIH
The NIH restructuring floated by two House Republicans Friday is the latest in an onslaught of GOP demands for agency reform and scrutiny. But they’re not alone in mulling change at the Bethesda campus. Even if a plan to whittle institutes down from 27 to 15 never takes flight, researchers and advocates say there’s room to work on director term limits, some institute mergers, and bringing back that elusive review board.
That sweeping changes could find traction — some even in the upcoming appropriations process — shows how once-bipartisan goals for NIH have splintered in the wake of the coronavirus pandemic and leadership shakeups.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect